Cheli Melzer-Cohen, from Maccabi Health Services in Tel Aviv, Israel, and colleagues examined the effect of subcutaneous semaglutide on HbA1c and weight reduction in a large cohort of adult patients treated for up to three years
Health in the Headlines brings together experts from opposing viewpoints to discuss timely health topics, encouraging conversation that transparently combines scientific evidence and personal, cultural, and policy values
When will we see GLP-1 bays in store
Triple Agonists (GLP-1 + GIP + Glucagon), designed to deliver even greater metabolic benefits
GLP1 receptor agonists have shown promise in achieving significant weight loss in PWS patients
This injection is usually done once a week and can be inserted subcutaneously in areas like the tummy, thigh, or upper arm